JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.12% |
| 2 | Financials | 12.1% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 8.72% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
2651
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.51M | ﹤0.01% |
+35,000
| New | +$3.38M |
|
|
CIM
2652
Chimera Investment
CIM
$993M
| $4.5M | ﹤0.01% |
72,946
-5,953
| -8% | -$363K |
|
2653
Ooma
OOMA
$553M
| $4.48M | ﹤0.01% |
338,235
-9,926
| -3% | -$121K |
|
2654
CALL
Caesars Entertainment
CZR
$6.04B
| $4.47M | ﹤0.01% |
75,000
| – | – |
|
|
2655
PUT
Caesars Entertainment
CZR
$6.04B
| $4.47M | ﹤0.01% |
75,000
| – | – |
|
|
ZGNX
2656
CALL
DELISTED
Zogenix, Inc.
ZGNX
| $4.47M | ﹤0.01% |
85,800
-238,100
| -74% | -$10.9M |
|
|
EVOP
2657
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $4.45M | ﹤0.01% |
168,577
-3,233
| -2% | -$89K |
|
|
SAFE
2658
Safehold
SAFE
$1.09B
| $4.45M | ﹤0.01% |
62,969
-128,404
| -67% | -$8.12M |
|
2659
Appian
APPN
$2.49B
| $4.44M | ﹤0.01% |
116,271
-156,534
| -57% | -$6.75M |
|
|
CLVS
2660
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.44M | ﹤0.01% |
426,043
+193,400
| +83% | +$1.41M |
|
2661
CALL
First Solar
FSLR
$24B
| $4.44M | ﹤0.01% |
79,300
-700
| -0.9% | -$38.4K |
|
2662
Coherent
COHR
$64B
| $4.43M | ﹤0.01% |
131,628
+16,739
| +15% | +$534K |
|
2663
TORM
TRMD
$3.01B
| $4.42M | ﹤0.01% |
407,491
+255,292
| +168% | +$2.43M |
|
2664
Middlesex Water
MSEX
$1.1B
| $4.41M | ﹤0.01% |
69,438
+19,879
| +40% | +$1.26M |
|
|
ARGO
2665
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $4.41M | ﹤0.01% |
67,099
+9,574
| +17% | +$626K |
|
2666
JPMorgan Ultra-Short Income ETF
JPST
$40.6B
| $4.41M | ﹤0.01% |
87,424
-374,916
| -81% | -$18.9M |
|
2667
Edgewell Personal Care
EPC
$1.32B
| $4.4M | ﹤0.01% |
142,199
+10,518
| +8% | +$339K |
|
|
MLPI
2668
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
| $4.4M | ﹤0.01% |
226,463
+67,655
| +43% | +$1.29M |
|
|
BLUE
2669
CALL
DELISTED
bluebird bio
BLUE
| $4.39M | ﹤0.01% |
+3,860
| New | +$4.2M |
|
2670
Enovis
ENOV
$1.42B
| $4.38M | ﹤0.01% |
69,949
+14,591
| +26% | +$825K |
|
2671
Greenlight Captial
GLRE
$505M
| $4.37M | ﹤0.01% |
432,268
+104,895
| +32% | +$1.09M |
|
|
CMBM
2672
DELISTED
Cambium Networks
CMBM
| $4.37M | ﹤0.01% |
500,009
-214,067
| -30% | -$1.66M |
|
|
SFBS
2673
ServisFirst Bancshares
SFBS
$5B
| $4.37M | ﹤0.01% |
115,925
+75,882
| +190% | +$2.71M |
|
2674
Gogo Inc
GOGO
$377M
| $4.36M | ﹤0.01% |
681,081
+654,697
| +2,481% | +$3.81M |
|
|
UHT
2675
Universal Health Realty Income Trust
UHT
$573M
| $4.35M | ﹤0.01% |
37,044
+5,304
| +17% | +$604K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.